AlfonsoJavierTafurMDMS. RPVI.

Cardiology, Vascular Medicine

Director, Vascular Medicine Northshore University Healthsystem Assistant Clinical Professor, Medicine, University of Chicago

Dr. Tafur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9650 Gross Point Rd
Fl 4
Skokie, IL 60076
Phone+1 847-663-8050

Fax+1 224-251-4407

Dr. Alfonso Tafur is a Physician Scientist in Skokie, IL and is affiliated with multiple hospitals in the area, including Evanston Hospital, Glenbrook Hospital, NorthShore Skokie Hospital, and Highland Park Hospital.

He received his medical degree from Universidad de Guayaquil Faculty of Medicine, Internal Medicine and Vascular Medicine training in Mayo Clinic, and a Masters in Clinical Research from University of Oklahoma.

Dr. Tafur has been in practice 14 years. He specializes in Vascular Medicine and is experienced in thrombophilias, cancer associated thrombosis, peri procedural anticoagulation management, and sneddon syndrome.

Loyola university MBA, Healthcare, 2020 - 2022
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
Universidad de Guayaquil, School of Medicine.Class of 2003
Okalhoma University HealthCenterMasters Degree, Clinical and Translational Research

PubMed

283 citations
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With C...
Alex C. Spyropoulos, Mark Goldin, Dimitrios Giannis, Wassim Diab, Janice Wang
JAMA Internal Medicine. 2021-10-07
155 citations
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, cont...
Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, Valéria Cristina Resende Aguiar, Alex C Spyropoulos
Lancet. 2022-01-01
22 citations
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
Eduardo Ramacciotti, Ariane Vieira Scarlatelli Macedo, Rodrigo Bruno Biagioni, Roberto Augusto Caffaro, Renato D. Lopes
Clinical and Applied Thrombosis/hemostasis. 2020-07-10

Abstracts/Posters

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban By Andexanet Alfa As Measured By Whole Blood Thromboelastographic Analysis
Alfonso J Tafur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Prothrombinase Induced Clotting Time Is More Sensitive then aPTT and PT and Can be Used for the Monitoring of Anti-Xa Agents in Whole Blood and Plasma
Alfonso J Tafur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Andexanet Alpha Differentially Neutralizes the Anticoagulant, Antiprotease and Thrombin Generation Inhibitory Effects of Unfractionated Heparin, Enoxaparin and Fondapa...
Alfonso J Tafur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

A Closer Look at the Possible Medical Complications from the Johnson and Johnson VaccineApril 13th, 2021
Most Don't Need 'Bridging' When They Stop Warfarin TemporarilyAugust 26th, 2015